Structure of PDB 5vp9 Chain A Binding Site BS01
Receptor Information
>5vp9 Chain A (length=198) [
Search protein sequence
] [
Download receptor structure
] [
Download structure with residue number starting from 1
] [
View receptor structure
]
MASMKKKGSVVIVGRINLSGDTAYAQQTRGEEGCQETSQTGRDKNQVEGE
VQIVSTATQTFLATSINGVLWTVYHGAGTRTIASPKGPVTQMYTNVDKDL
VGWQAPQGSRSLTPCTCGSSDLYLVTRHADVIPVRRRGDSRGSLLSPRPI
SYLKGSSGGPLLCPAGHAVGIFRAAVSTRGVAKAVDFIPVESLETTMR
Ligand information
Ligand ID
9H7
InChI
InChI=1S/C38H46N6O8S2/c1-37(2,3)52-36(48)41-28-15-8-6-4-5-7-12-23-21-38(23,35(47)43-54(49,50)25-17-18-25)42-32(45)29-20-24(22-44(29)34(28)46)51-33-31(30-16-11-19-53-30)39-26-13-9-10-14-27(26)40-33/h7,9-14,16,19,23-25,28-29H,4-6,8,15,17-18,20-22H2,1-3H3,(H,41,48)(H,42,45)(H,43,47)/b12-7-/t23-,24-,28+,29+,38-/m1/s1
InChIKey
XPJKLRKWYFSTBR-LZFWIHPHSA-N
SMILES
Software
SMILES
CACTVS 3.385
CC(C)(C)OC(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C1=O)Oc4nc5ccccc5nc4c6sccc6)C(=O)N[S](=O)(=O)C7CC7
CACTVS 3.385
CC(C)(C)OC(=O)N[CH]1CCCCCC=C[CH]2C[C]2(NC(=O)[CH]3C[CH](CN3C1=O)Oc4nc5ccccc5nc4c6sccc6)C(=O)N[S](=O)(=O)C7CC7
OpenEye OEToolkits 2.0.6
CC(C)(C)OC(=O)NC1CCCCCC=CC2CC2(NC(=O)C3CC(CN3C1=O)Oc4c(nc5ccccc5n4)c6cccs6)C(=O)NS(=O)(=O)C7CC7
OpenEye OEToolkits 2.0.6
CC(C)(C)OC(=O)N[C@H]1CCCCC/C=C\[C@@H]2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C1=O)Oc4c(nc5ccccc5n4)c6cccs6)C(=O)NS(=O)(=O)C7CC7
ACDLabs 12.01
c3(c1cccs1)c(nc2ccccc2n3)OC4CN5C(C4)C(NC6(C(C=CCCCCCC(C5=O)NC(=O)OC(C)(C)C)C6)C(NS(C7CC7)(=O)=O)=O)=O
Formula
C38 H46 N6 O8 S2
Name
ChEMBL
DrugBank
ZINC
PDB chain
5vp9 Chain A Residue 1201 [
Download ligand structure
] [
Download structure with residue number starting from 1
] [
View ligand structure
]
Receptor-Ligand Complex Structure
Global view
Local view
Structure summary
[
Spin on
] [
Spin off
] [
Reset
]
[
High quality
] [
Low quality
]
[
White background
] [
Black background
]
[
Spin on
] [
Spin off
] [
Reset
]
[
High quality
] [
Low quality
]
[
White background
] [
Black background
]
PDB
5vp9
Hepatitis C Virus NS3/4A Protease Inhibitors Incorporating Flexible P2 Quinoxalines Target Drug Resistant Viral Variants.
Resolution
1.859 Å
Binding residue
(original residue number in PDB)
Q1041 F1043 Y1056 H1057 V1078 D1081 L1135 K1136 G1137 S1139 F1154 R1155 A1156 A1157
Binding residue
(residue number reindexed from 1)
Q59 F61 Y74 H75 V96 D99 L153 K154 G155 S157 F172 R173 A174 A175
Annotation score
1
Binding affinity
MOAD
: Ki=1.03nM
PDBbind-CN
: -logKd/Ki=8.99,Ki=1.03nM
Enzymatic activity
Catalytic site (original residue number in PDB)
H1057 D1081 G1137 S1139
Catalytic site (residue number reindexed from 1)
H75 D99 G155 S157
Enzyme Commision number
2.7.7.48
: RNA-directed RNA polymerase.
3.4.21.98
: hepacivirin.
3.4.22.-
3.6.1.15
: nucleoside-triphosphate phosphatase.
3.6.4.13
: RNA helicase.
Gene Ontology
Molecular Function
GO:0008236
serine-type peptidase activity
Biological Process
GO:0006508
proteolysis
GO:0019087
transformation of host cell by virus
View graph for
Molecular Function
View graph for
Biological Process
External links
PDB
RCSB:5vp9
,
PDBe:5vp9
,
PDBj:5vp9
PDBsum
5vp9
PubMed
28594175
UniProt
P26664
|POLG_HCV1 Genome polyprotein
[
Back to BioLiP
]